Evidence map›Paper›PMID 29475987›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

A Novel Biological Role for Peptidyl-Arginine Deiminases: Citrullination of Cathelicidin LL-37 Controls the Immunostimulatory Potential of Cell-Free DNA.

Alicia Wong, Danuta Bryzek, Ewelina Dobosz, Carsten Scavenius, Pavel Svoboda, Maria Rapala-Kozik, Adam Lesner, Ivo Frydrych, Jan Enghild, Piotr Mydel and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Citrullination and the protein code: crosstalk between post-translational modifications in cancer.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  10. Review
  11. Article
  12. Review
  13. TLR2 Activation byFrontiers in immunology · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 5 countries.

Alicia WongDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, 30-387 Krakow, Poland.ORCID 0000-0002-6679-8436
Danuta BryzekDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, 30-387 Krakow, Poland.
Ewelina DoboszDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, 30-387 Krakow, Poland.
Carsten ScaveniusInterdisciplinary Nanoscience Center, Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0002-4304-0681
Pavel SvobodaDivision of Scientific Resources, Centers for Disease Control and Prevention, Atlanta, GA 30329.
Maria Rapala-KozikDepartment of Comparative Biochemistry and Bioanalytics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, 30-387 Krakow, Poland.
Adam LesnerFaculty of Chemistry, University of Gdansk, 80-309 Gdansk, Poland.ORCID 0000-0001-8335-3431
Ivo FrydrychInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 77126 Olomouc, Czech Republic.ORCID 0000-0003-1412-1607
Jan EnghildInterdisciplinary Nanoscience Center, Aarhus University, 8000 Aarhus, Denmark.ORCID 0000-0001-9292-9172
Piotr MydelDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, 30-387 Krakow, Poland.
Jan PohlDivision of Scientific Resources, Centers for Disease Control and Prevention, Atlanta, GA 30329.
Paul R ThompsonDepartment of Biochemistry and Molecular Pharmacology, UMass Medical School, Worcester, MA 01605; and.
Jan PotempaDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, 30-387 Krakow, Poland; joanna.koziel@uj.edu.pl jan.potempa@louisville.edu.
Joanna KozielDepartment of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University in Krakow, 30-387 Krakow, Poland; joanna.koziel@uj.edu.pl jan.potempa@louisville.edu.
Jagiellonian University · PLAarhus University · DKCenters for Disease Control and Prevention · USInstitute of Molecular and Translational Medicine · CZUniversity of Gdańsk · PLUniversity of Massachusetts Chan Medical School · US

Funding

Chemical probes to decipher PAD biologyR35GM118112 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Paul R Thompson · 2016 to 2026
$9.5M
Tracking the evolution of drug resistance for highly potent HIV protease inhibitoP01GM109767 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHIFFER, CELIA A. · 2014 to 2018
$8.0M
Bacterial peptidylarginine deiminase, a link between gums and joint diseaseR01DE022597 · NIDCR · UNIVERSITY OF LOUISVILLE · PI POTEMPA, JAN S · 2013 to 2023
$3.7M
Blocking of IL-6 function to prevent Pg mediated Th17 responseR21DE023207 · NIDCR · UNIVERSITY OF LOUISVILLE · PI POTEMPA, JAN S · 2013 to 2014
$413k
NIDCR NIH HHS R01 DE022597NIDCR NIH HHS R21 DE023207NIGMS NIH HHS P01 GM109767NIGMS NIH HHS R35 GM118112
6 · The paper itself

Abstract

LL-37, the only human cathelicidin that is released during inflammation, is a potent regulator of immune responses by facilitating delivery of oligonucleotides to intracellular TLR-9, thereby enhancing the response of human plasmacytoid dendritic cells (pDCs) to extracellular DNA. Although important for pathogen recognition, this mechanism may facilitate development of autoimmune diseases. In this article, we show that citrullination of LL-37 by peptidyl-arginine deiminases (PADs) hindered peptide-dependent DNA uptake and sensing by pDCs. In contrast, carbamylation of the peptide (homocitrullination of Lys residues) had no effect. The efficiency of LL-37 binding to oligonucleotides and activation of pDCs was found to be inversely proportional to the number of citrullinated residues in the peptide. Similarly, preincubation of carbamylated LL-37 with PAD2 abrogated the peptide's ability to bind DNA. Conversely, LL-37 with Arg residues substituted by homoarginine, which cannot be deiminated, elicited full activity of native LL-37 regardless of PAD2 treatment. Taken together, the data showed that citrullination abolished LL-37 ability to bind DNA and altered the immunomodulatory function of the peptide. Both activities were dependent on the proper distribution of guanidinium side chains in the native peptide sequence. Moreover, our data suggest that cathelicidin/LL-37 is citrullinated by PADs during NET formation, thus affecting the inflammatory potential of NETs. Together this may represent a novel mechanism for preventing the breakdown of immunotolerance, which is dependent on the response of APCs to self-molecules (including cell-free DNA); overactivation may facilitate development of autoimmunity.

Indexed as

AnimalsAntimicrobial Cationic PeptidesAutoimmunityBiological TransportCathelicidinsCell-Free Nucleic AcidsCell LineCitrullinationCitrullineDendritic CellsDNAHumansImmune ToleranceMiceProtein-Arginine DeiminasesRAW 264.7 CellsAntimicrobial Cationic PeptidesCathelicidinsCell-Free Nucleic AcidsCitrullineDNAProtein-Arginine Deiminases

Identifiers

PMID29475987
PMCPMC5860981
OpenAlexW2789021226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.